drugset / Trial / NCT07581145

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145

Phase 3 Recruiting 52 enrolled Bispebjerg Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.

Timeline

Start
2026-04-24
Primary completion
2028-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Semaglutide Peptide 1 mg Subcutaneous

Indications